|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 278.74 USD | +0.78% |
|
-0.71% | +9.20% |
| 01-28 | F5 Insider Sold Shares Worth $875,431, According to a Recent SEC Filing | MT |
| 01-28 | Morgan Stanley Adjusts F5 Price Target to $305 From $296, Maintains Equal Weight Rating | MT |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.74 | 5.08 | 6.39 | 7.68 | 8.29 | |||||
Return on Total Capital | 9.13 | 8.41 | 10.82 | 12.91 | 13.68 | |||||
Return On Equity % | 14.43 | 13.34 | 14.99 | 19.12 | 20.6 | |||||
Return on Common Equity | 14.43 | 13.34 | 14.99 | 19.12 | 20.6 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 81.3 | 79.98 | 78.91 | 80.2 | 81.41 | |||||
SG&A Margin | 45.05 | 44.33 | 40.58 | 39.1 | 38.3 | |||||
EBITDA Margin % | 21.5 | 19.79 | 23.13 | 27.49 | 28.62 | |||||
EBITA Margin % | 18.93 | 16.85 | 20.16 | 24.56 | 27.02 | |||||
EBIT Margin % | 17.06 | 15.5 | 19.12 | 23.69 | 25.63 | |||||
Income From Continuing Operations Margin % | 12.72 | 11.95 | 14.04 | 20.13 | 22.42 | |||||
Net Income Margin % | 12.72 | 11.95 | 14.04 | 20.13 | 22.42 | |||||
Net Avail. For Common Margin % | 12.72 | 11.95 | 14.04 | 20.13 | 22.42 | |||||
Normalized Net Income Margin | 10.49 | 9.26 | 12.25 | 15.63 | 16.88 | |||||
Levered Free Cash Flow Margin | 22.61 | 14.46 | 21.23 | 26.55 | 24.66 | |||||
Unlevered Free Cash Flow Margin | 22.61 | 14.46 | 21.23 | 26.55 | 24.66 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.54 | 0.52 | 0.53 | 0.52 | 0.52 | |||||
Fixed Assets Turnover | 5.39 | 6.48 | 7.39 | 8.1 | 9.2 | |||||
Receivables Turnover (Average Receivables) | 5.26 | 4.01 | 3.48 | 3.48 | 3.63 | |||||
Inventory Turnover (Average Inventory) | 19.49 | 11.94 | 11.38 | 9.94 | 7.47 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.16 | 1.04 | 1.26 | 1.42 | 1.56 | |||||
Quick Ratio | 1.05 | 0.91 | 1.11 | 1.25 | 1.4 | |||||
Operating Cash Flow to Current Liabilities | 0.46 | 0.24 | 0.44 | 0.53 | 0.59 | |||||
Days Sales Outstanding (Average Receivables) | 69.41 | 91.09 | 105.01 | 105.21 | 100.64 | |||||
Days Outstanding Inventory (Average Inventory) | 18.73 | 30.58 | 32.06 | 36.84 | 48.84 | |||||
Average Days Payable Outstanding | 48.03 | 54.59 | 57.43 | 40.14 | 48.22 | |||||
Cash Conversion Cycle (Average Days) | 40.11 | 67.08 | 79.64 | 101.91 | 101.26 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 30.31 | 26.92 | 10.03 | 7.97 | 7.29 | |||||
Total Debt / Total Capital | 23.26 | 21.21 | 9.12 | 7.39 | 6.79 | |||||
LT Debt/Equity | 27.4 | 11.03 | 8.56 | 6.9 | 6.42 | |||||
Long-Term Debt / Total Capital | 21.03 | 8.69 | 7.78 | 6.39 | 5.99 | |||||
Total Liabilities / Total Assets | 52.77 | 53.21 | 46.65 | 44.25 | 43.16 | |||||
Total Debt / EBITDA | 1.13 | 1.1 | 0.39 | 0.3 | 0.28 | |||||
Net Debt / EBITDA | -0.31 | -0.36 | -0.72 | -0.98 | -1.14 | |||||
Total Debt / (EBITDA - Capex) | 1.18 | 1.16 | 0.42 | 0.31 | 0.29 | |||||
Net Debt / (EBITDA - Capex) | -0.32 | -0.38 | -0.78 | -1.02 | -1.19 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 10.74 | 3.55 | 4.35 | 0.1 | 9.66 | |||||
Gross Profit, 1 Yr. Growth % | 8.87 | 1.87 | 2.95 | 1.74 | 11.32 | |||||
EBITDA, 1 Yr. Growth % | 7.44 | -4.67 | 21.96 | 18.99 | 14.16 | |||||
EBITA, 1 Yr. Growth % | 7.24 | -7.84 | 24.83 | 21.97 | 20.63 | |||||
EBIT, 1 Yr. Growth % | 4.51 | -5.93 | 28.74 | 24.03 | 18.61 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 7.74 | -2.74 | 22.59 | 43.51 | 22.16 | |||||
Net Income, 1 Yr. Growth % | 7.74 | -2.74 | 22.59 | 43.51 | 22.16 | |||||
Normalized Net Income, 1 Yr. Growth % | 1.86 | -8.61 | 38.02 | 27.7 | 18.42 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 6.59 | -1.31 | 24.29 | 45.8 | 23.56 | |||||
Accounts Receivable, 1 Yr. Growth % | 28.01 | 42.05 | 4.97 | -4.68 | 15.52 | |||||
Inventory, 1 Yr. Growth % | -20.94 | 209.98 | -47.53 | 112.91 | 1.11 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -17.7 | -9.27 | -7.52 | -10.05 | 4.08 | |||||
Total Assets, 1 Yr. Growth % | 6.83 | 5.58 | -0.53 | 6.95 | 12.59 | |||||
Tangible Book Value, 1 Yr. Growth % | -163.44 | -110.06 | 3.73K | 95.64 | 49.11 | |||||
Common Equity, 1 Yr. Growth % | 5.73 | 4.61 | 13.42 | 11.75 | 14.78 | |||||
Cash From Operations, 1 Yr. Growth % | -2.38 | -31.4 | 47.62 | 21.27 | 19.84 | |||||
Capital Expenditures, 1 Yr. Growth % | -48.86 | 9.7 | 61.15 | -43.87 | 42.25 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 2.09 | -33.78 | 53.19 | 25.2 | 1.81 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 2.09 | -33.78 | 53.19 | 25.2 | 1.81 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 7.75 | 7.09 | 3.95 | 2.21 | 4.77 | |||||
Gross Profit, 2 Yr. CAGR % | 5.94 | 5.31 | 2.41 | 2.34 | 6.42 | |||||
EBITDA, 2 Yr. CAGR % | -2.95 | 1.2 | 7.82 | 20.47 | 16.55 | |||||
EBITA, 2 Yr. CAGR % | -4.24 | -0.59 | 7.26 | 23.39 | 21.3 | |||||
EBIT, 2 Yr. CAGR % | -8.08 | -0.85 | 10.05 | 26.36 | 21.29 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -12 | 2.37 | 9.19 | 32.64 | 32.4 | |||||
Net Income, 2 Yr. CAGR % | -12 | 2.37 | 9.19 | 32.64 | 32.4 | |||||
Normalized Net Income, 2 Yr. CAGR % | -10.72 | -3.52 | 12.31 | 32.76 | 22.97 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -13.15 | 2.56 | 10.75 | 34.62 | 34.22 | |||||
Accounts Receivable, 2 Yr. CAGR % | 17.68 | 34.85 | 22.11 | 0.03 | 4.93 | |||||
Inventory, 2 Yr. CAGR % | -19.93 | 56.54 | 27.54 | 5.7 | 46.72 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 39.71 | -13.59 | -8.4 | -8.79 | -3.24 | |||||
Total Assets, 2 Yr. CAGR % | 21.41 | 6.2 | 2.48 | 3.14 | 9.73 | |||||
Tangible Book Value, 2 Yr. CAGR % | -60.09 | -74.74 | 96.36 | 765.93 | 70.79 | |||||
Common Equity, 2 Yr. CAGR % | 15.75 | 5.17 | 8.92 | 12.58 | 13.26 | |||||
Cash From Operations, 2 Yr. CAGR % | -7.12 | -18.16 | 0.63 | 33.8 | 20.56 | |||||
Capital Expenditures, 2 Yr. CAGR % | -45.59 | -25.1 | 32.96 | -4.9 | -10.65 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 14.83 | -17.78 | 0.72 | 38.49 | 12.9 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 14.83 | -17.78 | 0.72 | 38.49 | 12.9 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.4 | 6.33 | 6.17 | 2.65 | 4.63 | |||||
Gross Profit, 3 Yr. CAGR % | 5.55 | 4.57 | 4.52 | 2.19 | 5.25 | |||||
EBITDA, 3 Yr. CAGR % | -5.77 | -3.53 | 7.7 | 11.43 | 18.33 | |||||
EBITA, 3 Yr. CAGR % | -7.38 | -5.46 | 7.25 | 11.95 | 22.46 | |||||
EBIT, 3 Yr. CAGR % | -10 | -7.37 | 8.17 | 14.52 | 23.72 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -9.95 | -9.02 | 8.71 | 19.61 | 29.05 | |||||
Net Income, 3 Yr. CAGR % | -9.95 | -9.02 | 8.71 | 19.61 | 29.05 | |||||
Normalized Net Income, 3 Yr. CAGR % | -11.1 | -10.02 | 8.71 | 17.22 | 27.8 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -9.98 | -9.37 | 9.35 | 21.38 | 30.82 | |||||
Accounts Receivable, 3 Yr. CAGR % | 23.47 | 25.3 | 24.05 | 12.43 | 4.94 | |||||
Inventory, 3 Yr. CAGR % | -10.31 | 25.72 | 8.74 | 51.29 | 4.15 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 44.33 | 20.98 | -11.61 | -8.95 | -4.69 | |||||
Total Assets, 3 Yr. CAGR % | 24.25 | 15.89 | 3.91 | 3.95 | 6.2 | |||||
Tangible Book Value, 3 Yr. CAGR % | -48.84 | -74.79 | 34.74 | 96.12 | 381.75 | |||||
Common Equity, 3 Yr. CAGR % | 22.45 | 11.91 | 7.85 | 9.86 | 13.31 | |||||
Cash From Operations, 3 Yr. CAGR % | -5.36 | -16.04 | -0.38 | 7.09 | 28.98 | |||||
Capital Expenditures, 3 Yr. CAGR % | -16.93 | -31.27 | -3.31 | -0.26 | 8.76 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 0.75 | -4.42 | 1.18 | 8.3 | 24.99 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 0.75 | -4.42 | 1.18 | 8.3 | 24.99 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.47 | 5.22 | 5.41 | 4.66 | 5.61 | |||||
Gross Profit, 5 Yr. CAGR % | 5.01 | 4.42 | 4.28 | 3.67 | 5.28 | |||||
EBITDA, 5 Yr. CAGR % | -1.47 | -3.52 | -0.55 | 5.43 | 11.15 | |||||
EBITA, 5 Yr. CAGR % | -2.51 | -5.07 | -1.78 | 5.17 | 12.66 | |||||
EBIT, 5 Yr. CAGR % | -4.4 | -6.25 | -2.46 | 4.88 | 13.24 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -1.97 | -5.2 | -2.74 | 5.79 | 17.63 | |||||
Net Income, 5 Yr. CAGR % | -1.97 | -5.2 | -2.74 | 5.79 | 17.63 | |||||
Normalized Net Income, 5 Yr. CAGR % | -4.8 | -7.46 | -2.39 | 5.13 | 14.21 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -0.15 | -4.11 | -2.2 | 6.17 | 18.69 | |||||
Accounts Receivable, 5 Yr. CAGR % | 15.7 | 22.02 | 22.92 | 14.5 | 16.01 | |||||
Inventory, 5 Yr. CAGR % | -8.32 | 18.04 | 3.25 | 17.3 | 22.59 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 28.75 | 26.44 | 20.33 | 8.06 | -8.36 | |||||
Total Assets, 5 Yr. CAGR % | 16.72 | 16.33 | 15.03 | 10.61 | 6.2 | |||||
Tangible Book Value, 5 Yr. CAGR % | -30.55 | -56.88 | -12.38 | 3.74 | 48.15 | |||||
Common Equity, 5 Yr. CAGR % | 14.77 | 14.96 | 16.85 | 12.18 | 9.98 | |||||
Cash From Operations, 5 Yr. CAGR % | -1.94 | -9.77 | -3 | 1.16 | 7.52 | |||||
Capital Expenditures, 5 Yr. CAGR % | -13.55 | -2.76 | 0.27 | -21.73 | -6.31 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -0.03 | -10.04 | 0.74 | 10.86 | 5.71 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -0.03 | -10.04 | 0.74 | 10.86 | 5.71 |
- Stock Market
- Equities
- FFIV Stock
- Financials F5, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















